Word

NASADOSE

Status

Pending

Status Code

681

Status Date

Thursday, October 3, 2024

Serial Number

98218716

Mark Type

4

Filing Date

Wednesday, October 11, 2023

Published for Opposition

Tuesday, November 5, 2024

Trademark Owner History

Consort Medical Limited

Classifications

5 Drug delivery devices for medical purposes, namely, inhalers sold filled with inhalable pharmaceutical preparations for the treatment of infectious, viral, bacterial, metabolic, endocrine, exocrine, muscular, skeletal, cardiovascular, respiratory, reproductive, digestive, excretory, renal, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, lymphatic, integumentary, nervous, hormonal, dermatological, psychiatric and immunological related diseases and disorders; nasal inhalers for medical purposes, sold filled with inhalable pharmaceutical preparations for treating infectious, viral, bacterial, metabolic, endocrine, exocrine, muscular, skeletal, cardiovascular, respiratory, reproductive, digestive, excretory, renal, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, lymphatic, integumentary, nervous, hormonal, dermatological, psychiatric and immunological related diseases and disorders

10 Medical apparatus and instruments, namely, medical apparatus and instruments for use in delivering fluid to the respiratory system; medical apparatus and instruments, namely, drug delivery devices in the nature of nasal inhalers, sold empty; medical apparatus and instruments, namely, nasal inhalation devices being inhalers for medical purposes, sold empty; structural parts and fittings for all the aforesaid goods

NASA DOSE

Trademark Events

May 30, 2024

Assigned To Examiner

Oct 14, 2023

New Application Entered

Oct 16, 2023

New Application Office Supplied Data Entered

May 31, 2024

Non-Final Action Written

May 31, 2024

Notification Of Non-Final Action E-Mailed

May 31, 2024

Non-Final Action E-Mailed

Aug 30, 2024

Correspondence Received In Law Office

Aug 30, 2024

Teas/Email Correspondence Entered

Aug 30, 2024

Teas Response To Office Action Received

Sep 28, 2024

Examiner's Amendment Entered

Sep 28, 2024

Examiners Amendment E-Mailed

Sep 28, 2024

Examiners Amendment -Written

Sep 28, 2024

Notification Of Examiners Amendment E-Mailed

Sep 28, 2024

Approved For Pub - Principal Register